FluMist Live Virus Persistence: Duration and Immunological Role

FluMist (live attenuated influenza vaccine, LAIV) contains temperature-sensitive, cold-adapted strains that replicate in the cooler nasopharynx (33–34°C) but not lower respiratory tract (37°C).

Persistence Timeline

  • Detection window: Vaccine virus recoverable from nasal swabs for 3–14 days post-administration (peak days 2–5).
  • Clearance: Typically complete by 2 weeks; rarely up to 28 days in young children.
  • Shedding: Vaccinees can shed virus—caution around severely immunocompromised contacts for 7 days.

Immunological Purpose

Limited replication mimics natural infection, inducing:

  • Mucosal IgA (nasal, salivary) → blocks viral entry.
  • Systemic IgG (hemagglutination inhibition antibodies).
  • Cell-mediated immunity (CD8+ T cells) → cross-protective against drifted strains.

Contraindications

  • Immunocompromised patients and close contacts.
  • Pregnancy.
  • Age <2 or >49 years (per FDA labeling).
  • Asthma/wheezing in children 2–4 years.

Consult CDC/ACIP guidelines for current recommendations.

Viral Infections - Related Articles